Haloperidol Decanoate Injection
NDC 70771-1854
Product Information
Haloperidol Decanoate is a ANDA-approved product labeled by Zydus Lifesciences Limited. This medication is typically used as a typical antipsychotic [epc]. It is supplied as a injection for intramuscular administration. This product entry covers the primary NDC 70771-1854 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 70771-1854?
What are Active Ingredients of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- HALOPERIDOL DECANOATE (UNII: AC20PJ4101)
- HALOPERIDOL (UNII: J6292F8L3D) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SESAME OIL (UNII: QX10HYY4QV)
- BENZYL ALCOHOL (UNII: LKG8494WBH)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1719803 - haloperidol decanoate 100 MG in 1 ML Injection
- RxCUI: 1719803 - 1 ML haloperidol decanoate 100 MG/ML Injection
- RxCUI: 1719803 - haloperidol decanoate 100 MG per 1 ML Injection
- RxCUI: 1719862 - haloperidol decanoate 50 MG in 1 ML Injection
- RxCUI: 1719862 - 1 ML haloperidol decanoate 50 MG/ML Injection
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.